[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338014-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338014-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exosomal-thomsenfriedenreich-glycoantigen-a-new-liquid-biopsy-biomarker-for-lung-and-breast-cancer-diagnoses","Exosomal Thomsen–Friedenreich Glycoantigen - A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses","","Exosomes are nanosized extracellular vesicles that transport proteins and RNAs to support intercellular communication. Their roles in cancer development and metastasis have enabled exosomes to be explored as liquid biopsy biomarkers for screening, diagnosis, and management. While many exosomal cargos have been studied, carbohydrate biomarkers remain largely unexamined. This research reports an exosomal α-linked Thomsen–Friedenreich glycoantigen, TF-Ag-α, and establishes an mAb-based surface plasmon resonance assay to quantify it in blood, distinguishing lung and breast cancers from normal controls with high accuracy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exosomal-thomsenfriedenreich-glycoantigen-a-new-liquid-biopsy-biomarker-for-lung-and-breast-cancer-diagnoses/338014/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exosomal-thomsenfriedenreich-glycoantigen-a-new-liquid-biopsy-biomarker-for-lung-and-breast-cancer-diagnoses/338014.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is TF-Ag-α in this study?","Question",{"text":63,"@type":64},"TF-Ag-α is an α-linked Thomsen–Friedenreich glycoantigen carbohydrate marker carried by exosomes, described as Galβ1-3GalNAc-α.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers measure exosomal TF-Ag-α?",{"text":68,"@type":64},"They developed a surface plasmon resonance–based assay using a specific monoclonal antibody (mAb) named JAA-F11 to quantify exosomal TF-Ag-α in blood.",{"name":70,"@type":61,"acceptedAnswer":71},"How well did exosomal TF-Ag-α distinguish cancers from normal controls?",{"text":72,"@type":64},"With data from 233 participants, exosomal TF-Ag-α detected lung cancer and breast cancer from normal controls with ≥95% and ≥97% accuracy, respectively.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338014,1790179369,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-23-0505](https://doi.org/10.1158/2767-9764.CRC-23-0505)  OPEN ACCESS  \nExosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses  \nChang-Chieh Hsu1, Yafei Su1, Kate Rittenhouse-Olson2, Kristopher M. Attwood3, Wilfrido Mojica4, Mary E. Reid5, Grace K. Dy5, and Yun Wu1  \n􀀶  \nABSTRACT  \nExosomes are nanosized extracellular vesicles released by cells to transport biomolecules such as proteins and RNAs for intercellular communication. Exosomes play important roles in cancer development and metastasis; therefore, they have emerged as potential liquid biopsy biomarkers for cancer screening, diagnosis, and management. Many exosome cargos, including proteins, RNAs, and lipids, have been extensively investigated as biomarkers for cancer liquid biopsy. However, carbohydrates, an important type of biomolecule, have not yet been explored for this purpose. In this study, we reported a new exosomal carbohydrate biomarker, α-linked Thomsen–Friedenreich glycoantigen (TF-Ag-α; Galβ1-3GalNAc-α) . To translate our discovery into clinical settings, we developed a surface plasmon resonance–based assay which utilized a unique mAb, JAA-F11, with high specificity to measure the levels of exosomal TF-Ag-α in blood. To the best of our knowledge, we are the first to demonstrate that exosomes carry TF-Ag-α . We detected exosomal  \nTF-Ag-α in as low as 10 μL serum samples from patients with cancer, but in contrast, levels were negligible in those from normal controls. With a total of 233 patients with cancer and normal controls, we showed that exosomal TF-Ag-α detected lung cancer (n ¼ 60) and breast cancer (n ¼ 95) from normal controls (n ¼ 78) with ≥95% and ≥97% accuracy, respectively. These results demonstrated that exosomal TF-Ag-α is a potential liquid biopsy biomarker for cancer diagnosis.  \nSignificance: Exosomes or small extracellular vesicles have emerged as potent biomarkers of cancer liquid biopsy. We discovered a new exosomal carbohydrate marker, TF-Ag-α (Galβ1-3GalNAc-α), and showed that exosomal TF-Ag-α detected both lung and breast cancers with >95% accuracy. Our findings demonstrated that exosomal TF-Ag-α is a promising liquid biopsy biomarker for cancer screening and early detection.  \nIntroduction  \nExosomes are small extracellular vesicles released from cells that serve as important messengers to facilitate intercellular communication. Tumorderived exosomes (TEX) carry various biomolecules, including nucleic acids, proteins, and lipids, from their parental cells ( 1) and actively  \nparticipate in tumor initiation, development, and metastasis. Therefore,  \n1Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, New York. 2For-Robin, Inc., Buffalo, New York. 3Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 4Department of Pathology and Anatomical Sciences, University at Buffalo, The State University of New York, Buffalo, New York. 5Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Corresponding Authors: Yun Wu, Department of Biomedical Engineering, University at Buffalo, The State University of New York, 332 Bonner Hall, Buffalo, NY 14260. E-mail: [ywu32@buffalo.edu](ywu32@buffalo.edu); and Grace K. Dy, Department of Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm Street, Buffalo, NY 14203.  \nE-mail: [grace.dy@roswellpark.org](grace.dy@roswellpark.org)  \n[doi:](doi: 10.1158/2767-9764)[ 10.1158/2767-9764](doi: 10.1158/2767-9764) .CRC-23-0505  \nThis open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4. 0) license.  \n©2024 The Authors; Published by the American Association for Cancer Research  \nTEXs, especially their RNA and protein cargos, have become promising liquid biopsy biomarkers for cancer screening and diagnosis. In June 2019","cbCaijNczSvhwNjp","https://ap.wps.com/l/cbCaijNczSvhwNjp","pdf",7565038,13,"English","# Abstract\n# Significance\n# Introduction","[{\"question\":\"What is TF-Ag-α in this study?\",\"answer\":\"TF-Ag-α is an α-linked Thomsen–Friedenreich glycoantigen carbohydrate marker carried by exosomes, described as Galβ1-3GalNAc-α.\"},{\"question\":\"How did the researchers measure exosomal TF-Ag-α?\",\"answer\":\"They developed a surface plasmon resonance–based assay using a specific monoclonal antibody (mAb) named JAA-F11 to quantify exosomal TF-Ag-α in blood.\"},{\"question\":\"How well did exosomal TF-Ag-α distinguish cancers from normal controls?\",\"answer\":\"With data from 233 participants, exosomal TF-Ag-α detected lung cancer and breast cancer from normal controls with ≥95% and ≥97% accuracy, respectively.\"}]","Exosomal Thomsen–Friedenreich Glycoantigen - A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses | PDF",1790021581,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/529d43cbca8a436bb7b6a275a2607219.webp",983,1263,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb01ff23706156d60501a1312302815f.webp",982,1262,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbf6a0f91ab9a6ddb5874d47beaa453c.webp",981,1261,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6ed8d3c2f2e94e0cea6542fbd284da6.webp",980,1259]